W

The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.

Finance
Share
The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.

The first Phase 3 data for a cancer vaccine has raised questions about whether the potential new treatment is needed.

The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.

Source：MarketWatch

Disclaimer：Please read market information rationally and stay aware of investment risks. All content on this site is for informational purposes only and does not constitute investment advice.

Related Reading

Ripple wins final US approval for national trust bank

The approval clears the way for Ripple to manage reserves backing its RLUSD stablecoin and provide digital asset custody. Source：Cointelegraph

Dividend stocks are having an excellent October as tech sector struggles

ETFs focused on dividend stocks are seeing a powerful rally in October, adding to huge gains in 2026. Source：MarketWatch

Options traders are seizing control of the S&P 500

There’s a reason the index hasn’t moved much since June, according to a team at UBS. Source：MarketWatch

TikTok parent ByteDance’s chatbot is now giving travel-booking sites a run for their money. And yours.

Consumers in China are starting to wonder — for good reason — whether the emerging AI travel agents have a hidden agenda. Source：MarketWatch

Source：https://www.marketwatch.com/story/the-real-test-for-modernas-cancer-vaccine-isnt-about-beating-keytruda-its-keeping-cancer-from-coming-back-in-the-long-term-da9af99f